2024 Speakers

 

Howard Abroms, Vice President, Global Business Development, Soterius, Inc.

Howard Abroms | Vice President, Global Business Development | Soterius, Inc. » speaking at Drug Safety USA

Anthony Adamkovic, Executive Director, Pharmacovigilance, Harmony Biosciences, LLC

Anthony Adamkovic | Executive Director, Pharmacovigilance | Harmony Biosciences, LLC » speaking at Drug Safety USA

Ryan Ahern, MD, MPH, Chief Medical Officer and Co-founder, Truveta

Ryan Ahern, MD, MPH | Chief Medical Officer and Co-founder | Truveta » speaking at Drug Safety USA

Lois Ahn, Associate Director, PV Science, Alnylam Pharmaceuticals

Lois Ahn | Associate Director, PV Science | Alnylam Pharmaceuticals » speaking at Drug Safety USA

Vivek Ahuja, Senior Vice President, Compliance, EVERSANA

Vivek Ahuja | Senior Vice President, Compliance | EVERSANA » speaking at Drug Safety USA

Omar Aimer, Executive Member of ISoP and NASoP President, International Society of Pharmacovigilance (ISoP)

Omar Aimer | Executive Member of ISoP and NASoP President | International Society of Pharmacovigilance (ISoP) » speaking at Drug Safety USA

Timothy Allen, Global R&D Strategy Lead, HCL Technologies Ltd.

Timothy Allen | Global R&D Strategy Lead | HCL Technologies Ltd. » speaking at Drug Safety USA

Anand Ananthakrishnan, Senior Director, Drug Safety and Pharmacovigilance, Blueprint Medicines

Anand Ananthakrishnan | Senior Director, Drug Safety and Pharmacovigilance | Blueprint Medicines » speaking at Drug Safety USA

Maria Anitan, Global Head of Pharmacovigilance and Drug Safety, Med Communications Inc

Maria Anitan | Global Head of Pharmacovigilance and Drug Safety | Med Communications Inc » speaking at Drug Safety USA

Felix Arellano, Senior Vice President, Global Head of Pharmacovigilance and Drug Safety, Roche

Felix Arellano | Senior Vice President, Global Head of Pharmacovigilance and Drug Safety | Roche » speaking at Drug Safety USA

Charles Asare, Vice President, Head of Safety / Pharmacovigilance, Ionis Pharmaceuticals Inc

Charles Asare | Vice President, Head of Safety / Pharmacovigilance | Ionis Pharmaceuticals Inc » speaking at Drug Safety USA

Rex Atienza, Global Safety Director, Combination Product Safety, Amgen

Rex Atienza | Global Safety Director, Combination Product Safety | Amgen » speaking at Drug Safety USA

Nicole Baker, CEO, biologit

Nicole Baker | CEO | biologit » speaking at Drug Safety USA

Catherine Baldridge, Sr. Director Global Safety & Pharmacovigilance, Head of Safety, Fusion Pharma, a member of the AstraZeneca Group

Catherine Baldridge | Sr. Director Global Safety & Pharmacovigilance, Head of Safety | Fusion Pharma, a member of the AstraZeneca Group » speaking at Drug Safety USA

Michael Bani, Editor, Pharma Now

Michael Bani | Editor | Pharma Now » speaking at Drug Safety USA

Oliver Barnes, US Pharmaceutical & Biotech Correspondent, Financial Times

Oliver Barnes | US Pharmaceutical & Biotech Correspondent | Financial Times » speaking at Drug Safety USA

Victoria Bartasek, Senior Associate Director, Patient Safety and Pharmacovigilance - US Operations, Boehringer Ingelheim Pharma GmbH & Co. KG

Victoria Bartasek | Senior Associate Director, Patient Safety and Pharmacovigilance - US Operations | Boehringer Ingelheim Pharma GmbH & Co. KG » speaking at Drug Safety USA

Arvind Bellur, Executive Director - Head of PV Innovation and Transformation, CSL Behring

Arvind Bellur | Executive Director - Head of PV Innovation and Transformation | CSL Behring » speaking at Drug Safety USA

Anu Bhaskaran, NA Markets Lead – Life Sciences Digital Operations, Cognizant

Anu Bhaskaran | NA Markets Lead – Life Sciences Digital Operations | Cognizant » speaking at Drug Safety USA

Kapil Bhutada, Director of Safety Operations and Compliance, Medical Safety & Pharmacovigilance, AskBio

Kapil Bhutada | Director of Safety Operations and Compliance, Medical Safety & Pharmacovigilance | AskBio » speaking at Drug Safety USA

William Blumentals, Head of Pharmacoepidemiology, Specialty Care, Sanofi

William Blumentals | Head of Pharmacoepidemiology, Specialty Care | Sanofi » speaking at Drug Safety USA

Chris Bone, Director, Safety and Benefit Risk, Biogen

Chris Bone | Director, Safety and Benefit Risk | Biogen » speaking at Drug Safety USA

Emily Bratton, Category Lead, Safety Evidence for Regulators, IQVIA

Emily Bratton | Category Lead, Safety Evidence for Regulators | IQVIA » speaking at Drug Safety USA

Michael Braun-Boghos, Senior Director, Safety Strategy, Oracle Life Sciences

Michael Braun-Boghos | Senior Director, Safety Strategy | Oracle Life Sciences » speaking at Drug Safety USA

Jeff Brown, Chief Scientific Officer, TriNetX

Jeff Brown | Chief Scientific Officer | TriNetX » speaking at Drug Safety USA

Chinazo Brown, Safety physician, Neurocrine Biosciences

Chinazo Brown | Safety physician | Neurocrine Biosciences » speaking at Drug Safety USA

Jessica Brown, PV Director, Thermo Fisher Scientific

Jessica Brown | PV Director | Thermo Fisher Scientific » speaking at Drug Safety USA

Benjamin Brown, Executive Director, American Society of Pharmacovigilance

Benjamin Brown | Executive Director | American Society of Pharmacovigilance » speaking at Drug Safety USA

Siva Kumar Buddha, Director, Pharmacovigilance, Head of Signals and Risk Management, Indegene Inc.

Siva Kumar Buddha | Director, Pharmacovigilance, Head of Signals and Risk Management | Indegene Inc. » speaking at Drug Safety USA

Jane Carroll, VP, Medical Strategy and Operations, Moderna Therapeutics

Jane Carroll | VP, Medical Strategy and Operations | Moderna Therapeutics » speaking at Drug Safety USA

Dr Ananya Chakraborty, Professor and Incharge of ADR monitoring centre, Vydehi Institute of Medical Sciences & RC

Dr Ananya Chakraborty | Professor and Incharge of ADR monitoring centre | Vydehi Institute of Medical Sciences & RC » speaking at Drug Safety USA

Will Chamblin, Director, Strategic Accounts, Whatfix Inc.

Will Chamblin | Director, Strategic Accounts | Whatfix Inc. » speaking at Drug Safety USA

David T Chonzi, Independent Pharma Physician, Independent PV Expert

David T Chonzi | Independent Pharma Physician | Independent PV Expert » speaking at Drug Safety USA

Mugdha Chopra, Co-Founder and Director, AWINSA Life Sciences

Mugdha Chopra | Co-Founder and Director | AWINSA Life Sciences » speaking at Drug Safety USA

Eshara Chotoo, Chief Executive Officer, Antares Genomics

Eshara Chotoo | Chief Executive Officer | Antares Genomics » speaking at Drug Safety USA

Eric Cohen, Senior Medical Director, AbbVie

Eric Cohen | Senior Medical Director | AbbVie » speaking at Drug Safety USA

Abimbola Cole, Scientific Director, Safety Evaluation & Risk Management (SERM), GSK

Abimbola Cole | Scientific Director, Safety Evaluation & Risk Management (SERM) | GSK » speaking at Drug Safety USA

Juan Daccach, Vice President, Global Product Safety, Merz Aesthetics

Juan Daccach | Vice President, Global Product Safety | Merz Aesthetics » speaking at Drug Safety USA

Jay Dave, Technical Director, GPV & Risk Management, COD Research USA Inc.

Jay Dave | Technical Director, GPV & Risk Management | COD Research USA Inc. » speaking at Drug Safety USA

Karen De Jong, Executive Director Global Case Management, Boehringer Ingelheim

Karen De Jong | Executive Director Global Case Management | Boehringer Ingelheim » speaking at Drug Safety USA

Tasia-Leigh Deleon, Manager of Cosmetovigilance, CHANEL

Tasia-Leigh Deleon | Manager of Cosmetovigilance | CHANEL » speaking at Drug Safety USA

Sameen Desai, Executive Director, Head of Worldwide Patient Safety and Risk Management IT, bristol-myers squibb

Sameen Desai | Executive Director, Head of Worldwide Patient Safety and Risk Management IT | bristol-myers squibb » speaking at Drug Safety USA

Saurabh Dhiman, Global Head – CHC Digital Health and Science, Opella

Saurabh Dhiman | Global Head – CHC Digital Health and Science | Opella » speaking at Drug Safety USA

Melissa Douglas, VP of Recruiting Services, Orbis Clinical

Melissa Douglas | VP of Recruiting Services | Orbis Clinical » speaking at Drug Safety USA

Nancy Dubois, Senior Director, Head of Global Regions ad Interim, Global Patient Safety, EMD Serono

Nancy Dubois | Senior Director, Head of Global Regions ad Interim, Global Patient Safety | EMD Serono » speaking at Drug Safety USA

Doug Edmunds, Vice President of Operations, Wellgistics

Doug Edmunds | Vice President of Operations | Wellgistics » speaking at Drug Safety USA

Kal Elhoregy, Senior Director, Global Risk Management & Pharmacovigilance Compliance, Amneal Pharmaceuticals

Kal Elhoregy | Senior Director, Global Risk Management & Pharmacovigilance Compliance | Amneal Pharmaceuticals » speaking at Drug Safety USA

Katie Ellis Tupe, Senior Manager, US Patient Safety Operations, EMD Serono

Katie Ellis Tupe | Senior Manager, US Patient Safety Operations | EMD Serono » speaking at Drug Safety USA

Layo Emmanuel, Global Patient Safety Physician, JSC Farmak Pharmaceuticals

Layo Emmanuel | Global Patient Safety Physician | JSC Farmak Pharmaceuticals » speaking at Drug Safety USA

Maritess Esguerra, Senior PV Process Director for Safety Development and Processes, Genentech

Maritess Esguerra | Senior PV Process Director for Safety Development and Processes | Genentech » speaking at Drug Safety USA

Kevin Fetterman, Executive Director, Orbit By Feith Systems

Kevin Fetterman | Executive Director | Orbit By Feith Systems » speaking at Drug Safety USA

Scott Fonseca, Vice President and Managing Director, Integrated Safety, IQVIA

Scott Fonseca | Vice President and Managing Director, Integrated Safety | IQVIA » speaking at Drug Safety USA

Joshua Gagne, Vice President and Global Head of Epidemiology, Johnson & Johnson

Joshua Gagne | Vice President and Global Head of Epidemiology | Johnson & Johnson » speaking at Drug Safety USA

Nrupali Gandhi, Senior Director, PV Operations, Summit Therapeutics

Nrupali Gandhi | Senior Director, PV Operations | Summit Therapeutics » speaking at Drug Safety USA

Antara Gaur, Vice President, Pinnaxis Inc.

Antara Gaur | Vice President | Pinnaxis Inc. » speaking at Drug Safety USA

Julianne Gee, Senior Advisor, Immunization Safety Office, U.S. Centers for Disease Control and Prevention

Julianne Gee | Senior Advisor, Immunization Safety Office | U.S. Centers for Disease Control and Prevention » speaking at Drug Safety USA

Lisa George, Executive Director, Global Patient Safety Emerging Technology and Systems, Eli Lilly and Company

Lisa George | Executive Director, Global Patient Safety Emerging Technology and Systems | Eli Lilly and Company » speaking at Drug Safety USA

Jacqueline Gerena, Director, Risk Management Strategy, Johnson & Johnson

Jacqueline Gerena | Director, Risk Management Strategy | Johnson & Johnson » speaking at Drug Safety USA

Serban Ghiorghiu, Chief Safety Officer, AstraZeneca

Serban Ghiorghiu | Chief Safety Officer | AstraZeneca » speaking at Drug Safety USA

Rajesh Ghosh, Head, Digital Safety and Decision Support, Genentech

Rajesh Ghosh | Head, Digital Safety and Decision Support | Genentech » speaking at Drug Safety USA

Amrit Gill, VP - Global Head of Consumer Safety (PV) - Global Medical & Pharmacovigilance, Opella

Amrit Gill | VP - Global Head of Consumer Safety (PV) - Global Medical & Pharmacovigilance | Opella » speaking at Drug Safety USA

Katrina Goddard, Director of Global Drug Safety in Pharmacovigilance, Arriello

Katrina Goddard | Director of Global Drug Safety in Pharmacovigilance | Arriello » speaking at Drug Safety USA

Jennifer Goldsack, Chief Executive Officer, DiMe

Jennifer Goldsack | Chief Executive Officer | DiMe » speaking at Drug Safety USA

Kishore Gopu, Senior Director, REMS Operations, Teva Pharmaceuticals

Kishore Gopu | Senior Director, REMS Operations | Teva Pharmaceuticals » speaking at Drug Safety USA

Robert Gordon, Director, Statistics and Decision Sciences, Janssen

Robert Gordon | Director, Statistics and Decision Sciences | Janssen » speaking at Drug Safety USA

Jackie Grissinger, Director, RRA CoE, Johnson & Johnson

Jackie Grissinger | Director, RRA CoE | Johnson & Johnson » speaking at Drug Safety USA

Ramesh Gudalar, Global Head Markets - TCS Pharma Business Services and Platforms, Tata Consultancy Services

Ramesh Gudalar | Global Head Markets - TCS Pharma Business Services and Platforms | Tata Consultancy Services » speaking at Drug Safety USA

Alejandra Guerchicoff, Industry Leader, TCS ADD™ Platform, Tata Consultancy Services

Alejandra Guerchicoff | Industry Leader, TCS ADD™ Platform | Tata Consultancy Services » speaking at Drug Safety USA

Sepideh Habibi, Head of global PV and risk management, CRISPR Therapeutics

Sepideh Habibi | Head of global PV and risk management | CRISPR Therapeutics » speaking at Drug Safety USA

William Haddock, MPH, Vice President of Clinical Safety and Pharmacovigilance, Compass Pathways

William Haddock, MPH | Vice President of Clinical Safety and  Pharmacovigilance | Compass Pathways » speaking at Drug Safety USA

Paul Hayashi, DILI Team Lead, Division of Hepatology & Nutrition, FDA

Paul Hayashi | DILI Team Lead, Division of Hepatology & Nutrition | FDA » speaking at Drug Safety USA

Tina Hearty, Risk Management Lead, Johnson & Johnson

Tina Hearty | Risk Management Lead | Johnson & Johnson » speaking at Drug Safety USA

Peter Hjelmstrom, Director and Chief Executive Officer, Uppsala Monitoring Centre

Peter Hjelmstrom | Director and Chief Executive Officer | Uppsala Monitoring Centre » speaking at Drug Safety USA

Kevin Holman, Senior Director, REMS and Risk Management, Scientific Affairs, Johnson & Johnson

Kevin Holman | Senior Director, REMS and Risk Management, Scientific Affairs | Johnson & Johnson » speaking at Drug Safety USA

Martin Holm-Petersen, Chief Executive Officer, Insife - Chief Strategy Officer, Qinecsa Solutions

Martin Holm-Petersen | Chief Executive Officer, Insife - Chief Strategy Officer | Qinecsa Solutions » speaking at Drug Safety USA

Richard Huang, Senior Associate Director, Medical Safety, Boehringer Ingelheim

Richard Huang | Senior Associate Director, Medical Safety | Boehringer Ingelheim » speaking at Drug Safety USA

Ajinkya Inamdar, Senior Director (Global Medical Safety Strategy), BioNTech SE

Ajinkya Inamdar | Senior Director (Global Medical Safety Strategy) | BioNTech SE » speaking at Drug Safety USA

Namita Joshi, Regional PV Head North America, Opella

Namita Joshi | Regional PV Head North America | Opella » speaking at Drug Safety USA

Vineet Kacker, Managing Director, APCER Life Sciences

Vineet Kacker | Managing Director | APCER Life Sciences » speaking at Drug Safety USA

Jennifer Kane, Head of Pharmacovigilance, Innoviva Specialty Therapeutics

Jennifer Kane | Head of Pharmacovigilance | Innoviva Specialty Therapeutics » speaking at Drug Safety USA

Daniel Karlin, Chief Medical Officer, MindMed

Daniel Karlin | Chief Medical Officer | MindMed » speaking at Drug Safety USA

Mamiko Kasho, Executive Director, Eisai

Mamiko Kasho | Executive Director | Eisai » speaking at Drug Safety USA

Constantinos Katevatis, Associate Director, Life Sciences AI, IQVIA

Constantinos Katevatis | Associate Director, Life Sciences AI | IQVIA » speaking at Drug Safety USA

Brian Kaulback, Vice President, Technology Solutions -Safety & Logistics, Parexel

Brian Kaulback | Vice President, Technology Solutions -Safety & Logistics | Parexel » speaking at Drug Safety USA

Asad Kazi, Senior Global System Auditor, Bayer

Asad Kazi | Senior Global System Auditor | Bayer » speaking at Drug Safety USA

Scott Kelly, Senior Director, Epidemiology, Pfizer

Scott Kelly | Senior Director, Epidemiology | Pfizer » speaking at Drug Safety USA

Rahul Khajuria, Senior Director, Global Head of Drug Safety Systems and Analytics, United Therapeutics

Rahul Khajuria | Senior Director, Global Head of Drug Safety Systems and Analytics | United Therapeutics » speaking at Drug Safety USA

Arshi Khan, Chief Architect, Ultragenic Research & Technologies

Arshi Khan | Chief Architect | Ultragenic Research & Technologies » speaking at Drug Safety USA

Christina Kim, Senior Director, Vault Safety, Veeva Systems

Christina Kim | Senior Director, Vault Safety | Veeva Systems » speaking at Drug Safety USA

Ben Kitchens, Associate Director, Medical Devices, Digital and Diagnostics Lead, Otsuka

Ben Kitchens | Associate Director, Medical Devices, Digital and Diagnostics Lead | Otsuka » speaking at Drug Safety USA

George Kokoros, Co-Founder, BioPoint Inc

George Kokoros | Co-Founder | BioPoint Inc » speaking at Drug Safety USA

Brian Kraemer, Social Media Director, Genentech, A Member of the Roche Group

Brian Kraemer | Social Media Director | Genentech, A Member of the Roche Group » speaking at Drug Safety USA

Michael Kruczek, Senior Director, Vault Safety, Veeva Systems

Michael Kruczek | Senior Director, Vault Safety | Veeva Systems » speaking at Drug Safety USA

Elizabeth Kurian, Scientific Director, Safety Evaluation & Risk Management, GSK

Elizabeth Kurian | Scientific Director, Safety Evaluation & Risk Management | GSK » speaking at Drug Safety USA

Graeme Ladds, CEO & Owner, PharSafer

Graeme Ladds | CEO & Owner | PharSafer » speaking at Drug Safety USA

Geneviève Larouche, Global Director, Pharmacovigilance and Medical Information, Knight Therapeutics

Geneviève Larouche | Global Director, Pharmacovigilance and Medical Information | Knight Therapeutics » speaking at Drug Safety USA

Jim Leaver, VP, Global Medical Information, PrimeVigilance

Jim Leaver | VP, Global Medical Information | PrimeVigilance » speaking at Drug Safety USA

Lindsay Leming, Senior Director Pharmacovigilance, Thermo Fisher Scientific

Lindsay Leming | Senior Director Pharmacovigilance | Thermo Fisher Scientific » speaking at Drug Safety USA

Julie Levine, Executive Medical Director MSERM, Thermo Fisher Scientific

Julie Levine | Executive Medical Director MSERM | Thermo Fisher Scientific » speaking at Drug Safety USA

Mariette M Boerstoel, Senior Vice President, Worldwide Patient Safety Officer, Bristol Myers Squibb

Mariette M Boerstoel | Senior Vice President, Worldwide Patient Safety Officer | Bristol Myers Squibb » speaking at Drug Safety USA

Han Ma, SVP, Chief Safety Officer, BeiGene

Han Ma | SVP, Chief Safety Officer | BeiGene » speaking at Drug Safety USA

Philisha Mack, Director of Drug Safety, Azurity Pharmaceuticals

Philisha Mack | Director of Drug Safety | Azurity Pharmaceuticals » speaking at Drug Safety USA

Steve Madsen, Chief Executive Officer, Rx ERP

Steve Madsen | Chief Executive Officer | Rx ERP » speaking at Drug Safety USA

Parth Majmudar, Risk Management Lead, Johnson & Johnson

Parth Majmudar | Risk Management Lead | Johnson & Johnson » speaking at Drug Safety USA

Claudia Manzo, Head of the Office of Risk Management, Pharmacovigilance and Patient Safety, AbbVie

Claudia Manzo | Head of the Office of Risk Management, Pharmacovigilance and Patient Safety | AbbVie » speaking at Drug Safety USA

Laurie McRae, Vice President, Solution Consulting & Account Mgt - Safety & Log, parexel

Laurie McRae | Vice President, Solution Consulting & Account Mgt - Safety & Log | parexel » speaking at Drug Safety USA

Reema Mehta, Vice President, Head of Risk Assessment and Management, Pfizer

Reema Mehta | Vice President, Head of Risk Assessment and Management | Pfizer » speaking at Drug Safety USA

Bruno Mendez, Vice President Global Head Medical and Pharmacovigilance Quality, Sanofi

Bruno Mendez | Vice President Global Head Medical and Pharmacovigilance Quality | Sanofi » speaking at Drug Safety USA

Tarik Messaoud, Drug Safety Physician, Access Clinical Research

Tarik Messaoud | Drug Safety Physician | Access Clinical Research » speaking at Drug Safety USA

Vasu Miduturu, Director, Pharmacovigilance operations, Tango Therapeutics

Vasu Miduturu | Director, Pharmacovigilance operations | Tango Therapeutics » speaking at Drug Safety USA

Sanjeev Miglani, Founder and Director, AWINSA Life Sciences

Sanjeev Miglani | Founder and Director | AWINSA Life Sciences » speaking at Drug Safety USA

Lena Mishalov, Executive Director, Head of PV Transformation and Technology, Astellas

Lena Mishalov | Executive Director, Head of PV Transformation and Technology | Astellas » speaking at Drug Safety USA

Anna Monaco, Associate Director, Pharmacovigilance Partner Strategy & Management, Merck

Anna Monaco | Associate Director, Pharmacovigilance Partner Strategy & Management | Merck » speaking at Drug Safety USA

Madhu Mondal, Senior Director, Head of Toxicology, Cerevel therapeutics

Madhu Mondal | Senior Director, Head of Toxicology | Cerevel therapeutics » speaking at Drug Safety USA

Manju Morrissey, Global Safety Lead - Oncology Programs, Moderna

Manju Morrissey | Global Safety Lead - Oncology Programs | Moderna » speaking at Drug Safety USA

Rania Mouchantaf, Executive Director, Health Canada

Rania Mouchantaf | Executive Director | Health Canada » speaking at Drug Safety USA

Michael Murphy, Associate Vice President, Head of Pharmacovigilance Operations, Amgen

Michael Murphy | Associate Vice President, Head of Pharmacovigilance Operations | Amgen » speaking at Drug Safety USA

Meera Nagaria, Senior Data Scientist, Johnson & Johnson

Meera Nagaria | Senior Data Scientist | Johnson & Johnson » speaking at Drug Safety USA

Sumit Nagpal, Senior Director, Digital Insights and Data Governance,Analytics, Reporting & Data Governance, Worldwide Patient Safety, bristol-myers squibb

Sumit Nagpal | Senior Director, Digital Insights and Data Governance,Analytics, Reporting & Data Governance, Worldwide Patient Safety | bristol-myers squibb » speaking at Drug Safety USA

Narayan Nair, Division Director for Division of Pharmacovigilance, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration

Narayan Nair | Division Director for Division of Pharmacovigilance, Center for Biologics Evaluation and Research | U.S. Food and Drug Administration » speaking at Drug Safety USA

Jaylaxmi Nalawade, Director, Pharmacovigilance and REMS, Lupin

Jaylaxmi Nalawade | Director, Pharmacovigilance and REMS | Lupin » speaking at Drug Safety USA

Yvonne Nanciu, Country Head, Pharmacovigilance, Deputy EU QPPV, Bayer

Yvonne Nanciu | Country Head, Pharmacovigilance, Deputy EU QPPV | Bayer » speaking at Drug Safety USA

Valatine Ngwashi, Drug Safety Physician, Incyte

Valatine Ngwashi | Drug Safety Physician | Incyte » speaking at Drug Safety USA

Bruno Ohana, CTO, biologit

Bruno Ohana | CTO | biologit » speaking at Drug Safety USA

Sally Omidvar, VP of Partner Research and Success, Truveta

Sally Omidvar | VP of Partner Research and Success | Truveta » speaking at Drug Safety USA

Ann-Marie Orange, Chief Information Officer and Global Head of R&D, ArisGlobal

Ann-Marie Orange | Chief Information Officer and Global Head of R&D | ArisGlobal » speaking at Drug Safety USA

Karthik Babu P S, CHC Global PV Operations Head, Opella

Karthik Babu P S | CHC Global PV Operations Head | Opella » speaking at Drug Safety USA

Bruce Palsulich, Vice President, Safety, Oracle Life Sciences

Bruce Palsulich | Vice President, Safety | Oracle Life Sciences » speaking at Drug Safety USA

Rena Pandit, Exec Director, Global Patient Safety Head of Compliance & Training, Amgen

Rena Pandit | Exec Director, Global Patient Safety Head of Compliance & Training | Amgen » speaking at Drug Safety USA

Chintan Patel, Associate Director, PV QA and Compliance, Ionis Pharmaceuticals - San Diego, CA

Chintan Patel | Associate Director, PV QA and Compliance | Ionis Pharmaceuticals - San Diego, CA » speaking at Drug Safety USA

Badrish Patel, M.D., Vice President, Global Drug Safety and Pharmacovigilance, Jazz Pharmaceuticals

Badrish Patel, M.D. | Vice President, Global Drug Safety and Pharmacovigilance | Jazz Pharmaceuticals » speaking at Drug Safety USA

Elena Persiantsev, Director, Life Sciences Practice, Point B

Elena Persiantsev | Director, Life Sciences Practice | Point B » speaking at Drug Safety USA

Jan Petracek, Chief Executive Officer, iVigee

Jan Petracek | Chief Executive Officer | iVigee » speaking at Drug Safety USA

Anuradha Prabhakar, Associate Director of Product Management, IQVIA

Anuradha Prabhakar | Associate Director of Product Management | IQVIA » speaking at Drug Safety USA

Kamlesh Prabhu, Director-Medical Safety, BioNTech SE

Kamlesh Prabhu | Director-Medical Safety | BioNTech SE » speaking at Drug Safety USA

Alison Purdon, Director, MAP & Digital Engagement, US Patient Safety, Genentech A Member of the Roche Group Inc

Alison Purdon | Director, MAP & Digital Engagement, US Patient Safety | Genentech A Member of the Roche Group Inc » speaking at Drug Safety USA

Alex Qiu, Executive Director and Therapeutic Area Lead, Early Development and External Partnerships, Bristol Myers Squibb

Alex Qiu | Executive Director and Therapeutic Area Lead, Early Development and External Partnerships | Bristol Myers Squibb » speaking at Drug Safety USA

Abdul Rahim, Founder Director, ALWIS Solutions Limited

Abdul Rahim | Founder Director | ALWIS Solutions Limited » speaking at Drug Safety USA

Asad Rashid, Vice President, Syneos Health LLC

Asad Rashid | Vice President | Syneos Health LLC » speaking at Drug Safety USA

Amrit Ray, Chairman of the Board, Arisglobal LLC

Amrit Ray | Chairman of the Board | Arisglobal LLC » speaking at Drug Safety USA

Lisa Reeber, Associate Director, Patient Safety IT Lead, Merck

Lisa Reeber | Associate Director, Patient Safety IT Lead | Merck » speaking at Drug Safety USA

Arie Regev, Vice President, Medical Global Patient Safety, Lilly and Company

Arie Regev | Vice President, Medical Global Patient Safety | Lilly and Company » speaking at Drug Safety USA

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI

Pav Rishiraj | Director, Head of Patient Safety & ABPI PV Expert Chair | Ipsen & ABPI » speaking at Drug Safety USA

Angie Robertson, Director, Systems and Submissions, ProPharma

Angie Robertson | Director, Systems and Submissions | ProPharma » speaking at Drug Safety USA

Sara Rogers, President, American Society of Pharmacovigilance

Sara Rogers | President | American Society of Pharmacovigilance » speaking at Drug Safety USA

Jonathon Romero, AI and Machine Learning Specialist, Syneos Health

Jonathon Romero | AI and Machine Learning Specialist | Syneos Health » speaking at Drug Safety USA

Satya Sagi, Founder & CEO, Techsol Life sciences

Satya Sagi | Founder & CEO | Techsol Life sciences » speaking at Drug Safety USA

Magda Santos, Director of Pharmacovigilance, Thermo Fisher Scientific

Magda Santos | Director of Pharmacovigilance | Thermo Fisher Scientific » speaking at Drug Safety USA

Milind Sardesai, Senior Director, Safety Surveillance, Global Patient Safety, Novo Nordisk

Milind Sardesai | Senior Director, Safety Surveillance, Global Patient Safety | Novo Nordisk » speaking at Drug Safety USA

E. Alton Sartor, Medical Director, Safety Digital and Devices, AstraZeneca

E. Alton Sartor | Medical Director, Safety Digital and Devices | AstraZeneca » speaking at Drug Safety USA

Sushama Scalera, Managing Director, scalera consulting group LLC

Sushama Scalera | Managing Director | scalera consulting group LLC » speaking at Drug Safety USA

Anja Schaefer, VP & Global Head of Commercial, Life Sciences, Welocalize

Anja Schaefer | VP & Global Head of Commercial, Life Sciences | Welocalize » speaking at Drug Safety USA

Nikesh Shah, Vice President and Global Head, Drug Safety and Pharmacovigilance, Indegene

Nikesh Shah | Vice President and Global Head, Drug Safety and Pharmacovigilance | Indegene » speaking at Drug Safety USA

Beth Shaleesh, Head of North America Account Management, Safety and Vigilance, ProductLife Group

Beth Shaleesh | Head of North America Account Management, Safety and Vigilance | ProductLife Group » speaking at Drug Safety USA

Jim Shamp, Vice President, Data Intelligence & Program Analytics, UBC

Jim Shamp | Vice President, Data Intelligence & Program Analytics | UBC » speaking at Drug Safety USA

Vedaant Shourie, Safety System SME, Pinnaxis Inc.

Vedaant Shourie | Safety System SME | Pinnaxis Inc. » speaking at Drug Safety USA

Mallika Singh, Doctor of Public Health (DrPH), New York Medical College

Mallika Singh | Doctor of Public Health (DrPH) | New York Medical College » speaking at Drug Safety USA

Karam Veer Singh, Head of Global Markets, Solutions & Partnerships, Tata Consultancy Services

Karam Veer Singh | Head of Global Markets, Solutions & Partnerships | Tata Consultancy Services » speaking at Drug Safety USA

Parul Singla, Senior Director, Clinical Safety and Pharmacovigilance, Soterius, Inc.

Parul Singla | Senior Director, Clinical Safety and Pharmacovigilance | Soterius, Inc. » speaking at Drug Safety USA

Scott Skellenger, VP – Digital, Technology, and Innovation – R&D Informatics & Global Infrastructure Services, Amgen

Scott Skellenger | VP – Digital, Technology, and Innovation – R&D Informatics & Global Infrastructure Services | Amgen » speaking at Drug Safety USA

Srinivasan Srinivasan Muthusamy, Director - Safety Reporting, BeiGene

Srinivasan Srinivasan Muthusamy | Director - Safety Reporting | BeiGene » speaking at Drug Safety USA

Melanie Stephenson, Managing Director, Consulting, Deloitte

Melanie Stephenson | Managing Director, Consulting | Deloitte » speaking at Drug Safety USA

Sameer Thapar, Strategic Client Advisor, Oracle Life Sciences

Sameer Thapar | Strategic Client Advisor | Oracle Life Sciences » speaking at Drug Safety USA

Julie Thomas, Vice President, Global Medical Safety Operations, Janssen

Julie Thomas | Vice President, Global Medical Safety Operations | Janssen » speaking at Drug Safety USA

Danielle Thomas, Life Sciences Customer Consultant, Elsevier

Danielle Thomas | Life Sciences Customer Consultant | Elsevier » speaking at Drug Safety USA

Sam Tomlinson, VP Global Drug Safety, Arriello

Sam Tomlinson | VP Global Drug Safety | Arriello » speaking at Drug Safety USA

Kelly Traverso, Life Sciences R&D Business Development Leader, Deloitte

Kelly Traverso | Life Sciences R&D Business Development Leader | Deloitte » speaking at Drug Safety USA

Uwe Trinks, Global Practice Leader, IQVIA

Uwe Trinks | Global Practice Leader | IQVIA » speaking at Drug Safety USA

Ujjval Trivedi, Global System Auditor, Bayer

Ujjval Trivedi | Global System Auditor | Bayer » speaking at Drug Safety USA

Krishna Trivedi, Associate Director, Pharmacovigilance Operations, Haleon

Krishna Trivedi | Associate Director, Pharmacovigilance Operations | Haleon » speaking at Drug Safety USA

Dennis Van Liew, Board Member Emeritus, Personalized Medicine Coalition

Dennis Van Liew | Board Member Emeritus | Personalized Medicine Coalition » speaking at Drug Safety USA

Sriram Varma, Senior Vice President, PV Services, Techsol Life sciences

Sriram Varma | Senior Vice President, PV Services | Techsol Life sciences » speaking at Drug Safety USA

Jose Vega, Chief Safety Officer, Moderna, Inc.

Jose Vega | Chief Safety Officer | Moderna, Inc. » speaking at Drug Safety USA

Tina Veizovic, Senior Director, GPS International and PV Partnerships, BeiGene

Tina Veizovic | Senior Director, GPS International and PV Partnerships | BeiGene » speaking at Drug Safety USA

Ram Vempati, Senior Safety Physician, BioNTech

Ram Vempati | Senior Safety Physician | BioNTech » speaking at Drug Safety USA

Sreelakshmi Venkataperumal, Director, Alliance Management, Patient Safety & Pharmacovigilance, Sanofi

Sreelakshmi Venkataperumal | Director, Alliance Management, Patient Safety & Pharmacovigilance | Sanofi » speaking at Drug Safety USA

Venkat Venkataramanan, PV Practice Lead, Cognizant

Venkat Venkataramanan | PV Practice Lead | Cognizant » speaking at Drug Safety USA

Javier Waksman, Independent Drug Safety Consultant, Former Head of Global Drug Safety, Cerevel therapeutics

Javier Waksman | Independent Drug Safety Consultant, Former Head of Global Drug Safety | Cerevel therapeutics » speaking at Drug Safety USA

Suneet Walia, CEO, Soterius, Inc.

Suneet Walia | CEO | Soterius, Inc. » speaking at Drug Safety USA

Aman Wasan, Chief Executive Officer, Arisglobal LLC

Aman Wasan | Chief Executive Officer | Arisglobal LLC » speaking at Drug Safety USA

Jennifer White, Director Pharmacovigilance, Thermo Fisher Scientific

Jennifer White | Director Pharmacovigilance | Thermo Fisher Scientific » speaking at Drug Safety USA

Annette Williams, Vice President, Global Lifecycle Safety, Data Sciences, Safety and Medical, IQVIA

Annette Williams | Vice President, Global Lifecycle Safety, Data Sciences, Safety and Medical | IQVIA » speaking at Drug Safety USA

Richard Wolf, Vice President, Client Relations, RxLogix Corporation

Richard Wolf | Vice President, Client Relations | RxLogix Corporation » speaking at Drug Safety USA

Beena Wood, Global Head of Case Management and Transformation, CSL Behring

Beena Wood | Global Head of Case Management and Transformation | CSL Behring » speaking at Drug Safety USA

Kirthi Kiran Yadagiri, Sr. Manager, Clinical Data Analytics & Engineering - Data Science & Operational Excellence, BeiGene

Kirthi Kiran Yadagiri | Sr. Manager, Clinical Data Analytics & Engineering - Data Science & Operational Excellence | BeiGene » speaking at Drug Safety USA

Carla Yokoyama, Global Head of Safety Network, Roche

Carla Yokoyama | Global Head of Safety Network | Roche » speaking at Drug Safety USA

Renata Yoshida, Head International Patient Safety - Latin America & Canada, Hoffman La Roche

Renata Yoshida | Head International Patient Safety - Latin America & Canada | Hoffman La Roche » speaking at Drug Safety USA

Elena Yureneva, Executive Director, Head of Medical Safety and Risk Management, Alnylam Pharmaceuticals

Elena Yureneva | Executive Director, Head of Medical Safety and Risk Management | Alnylam Pharmaceuticals » speaking at Drug Safety USA

Jinfeng Zhang, Professor, Florida State University

Jinfeng Zhang | Professor | Florida State University » speaking at Drug Safety USA

Oleg Zvenigorodsky, Director, Medical Safety / Innovation Lead, Jazz Pharmaceuticals

Oleg Zvenigorodsky | Director, Medical Safety / Innovation Lead | Jazz Pharmaceuticals » speaking at Drug Safety USA

Get Involved At Drug Safety Congress Americas

 

CONNECT WITH US

 

For Sponsorship and Exhibition opportunities

Semen Sen
semen.sen@terrapinn.com
t/ + 646-619-1793

 

To Speak
 

Kaylee Nguyen
kaylee.nguyen@terrapinn.com

 

Marketing & Press
Opportunities

Kaylie Brogan
kaylie.brogan@terrapinn.com